Si Chuan Venture Capital

Total investments

15

Average round size

6M

Portfolio companies

14

Rounds per year

1.67

Lead investments

4

Follow on index

0.07

Stages of investment
Early Stage Venture
Areas of investment
AutomotiveLogisticsBiotechnologyInternetSoftwareInformation TechnologyHealth CareEducationMedicalPharmaceutical

Investments analytics

Analytics

Total investments
15
Lead investments
4
Rounds per year
1.67
Follow on index
0.07
Investments by industry
  • Medical (5)
  • Pharmaceutical (4)
  • Biotechnology (4)
  • Health Care (3)
  • Automotive (2)
  • Show 24 more
Investments by region
  • China (15)
Peak activity year
2019

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
6
Group Appearance index
0.87

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company nameDeal dateIndustryDeal stageDeal sizeLocation
IDEATE Medical01 Jan 2019Health Care, Medical Device, MedicalEarly Stage Venture4M
New Radiomedicine Technology14 Mar 2024Biotechnology, Health Care, MedicalLate Stage Venture46MSichuan, Qingyang District, China
Spherics17 Feb 2000Biotechnology, Manufacturing, Pharmaceutical, BiopharmaEarly Stage Venture4MUnited States, Massachusetts
Stork Healthcare01 Apr 2019Health Care, MedicalEarly Stage VentureSichuan, Qingyang District, China

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.